
Drug repurposing can be a cost-effective means of addressing unmet medical needs.

Recent Advances in Transporter Testing Strategies Enable Effective Identification of Potential Drug-Drug Interactions

Profiling an Oncology Drug with In Vitro Assays and In Vivo Models to Better Understand its Potential Clinical Applications

Beacon Discovery celebrates first anniversary and announces collaborations with two San Diego start-ups

Selcia Discovery scientists continue to support Cypralis with integrated drug discovery services on their third successful Innovate UK award to identify novel inhibitors for fibrosis

Beacon Discovery Inc., launches as new GPCR-focused drug discovery incubator